Spi-Gcf-104
Research payments
$404,472
Through program year 2025, $404,472 in research payments was reported against Spi-Gcf-104, across 31 payments, paid by Spectrum Pharmaceuticals Inc..
- Paid by
- Spectrum Pharmaceuticals Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $94,388 | 9 |
| 2024 | Research | $310,084 | 22 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Manuel Modiano Tucson, AZ Named on 11 payments
- James Kim Youngstown, OH Named on 8 payments
- Omkar Marathe Lakewood, CA Named on 4 payments
- Ahmad El-Far Winter Haven, FL Named on 2 payments
- Lee Schwartzberg Reno, NV Named on 2 payments
- Sashi Naidu Rock Hill, SC Named on 1 payment
- Angela Saverimuthu Phoenix, AZ Named on 1 payment
- Jason Tache Plantation, FL Named on 1 payment
- Richard Zuniga Babylon, NY Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.